Providing Insight Into and Mindfulness for Situational Erectile Dysfunction
Launched by VANCOUVER COASTAL HEALTH · Apr 7, 2020
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is exploring a new approach to help men who experience situational erectile dysfunction (ED), which means they have trouble achieving or maintaining an erection in specific situations, often related to stress or anxiety. The study will test a program called mindfulness-based psychosexual therapy (MBPST), which consists of six group sessions designed to help participants better understand their sexual challenges and develop healthier coping strategies. Researchers want to see if this therapy can improve sexual functioning, relationship satisfaction, and whether participants find the treatment acceptable.
To participate in this trial, men must be at least 19 years old and have been diagnosed with situational ED for at least six months. They should be comfortable joining a small group of 6-10 people and willing to stop using any medications for ED during the treatment period. However, the study is not suitable for those who have ongoing health issues that could interfere with participation or who don’t feel comfortable in a group setting. Participants can expect a supportive environment where they can share experiences and learn mindfulness techniques to help improve their sexual health.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- This study is open to individuals who are:
- • Diagnosed with situational erectile dysfunction (ED) of at least 6 months duration, as assessed by a physician at the BC Centre for Sexual Medicine according to DSM-5 criteria
- • 19 years of age or older
- • Fluent enough in English to participate in group
- • Willing to abstain from using medications for ED (i.e., PDE5 inhibitors, intracavernosal injections, MUSE etc.) from the start of treatment until the 1-month follow-up (totaling 10 weeks)
- • Comfortable and interested in participating in a small group format with 6-10 others
- Exclusion Criteria:
- This study is not suitable for individuals who:
- • Do not experience an exacerbation of ED in the partnered context
- • Have a current unmanaged health condition (e.g., unmanaged diabetes mellitus) or unstable mental health condition (e.g., severe depression/anxiety, active suicidal ideation) that would interfere with self- or partnered-sexual activities or with group participation
- • Do no feel comfortable participating in a small group format with 6-10 others
About Vancouver Coastal Health
Vancouver Coastal Health (VCH) is a leading health authority in British Columbia, Canada, dedicated to delivering high-quality healthcare services to a diverse population. With a strong commitment to research and innovation, VCH sponsors clinical trials aimed at advancing medical knowledge and improving patient outcomes. The organization collaborates with academic institutions, healthcare professionals, and industry partners to facilitate groundbreaking studies across a wide range of therapeutic areas. VCH prioritizes ethical standards and regulatory compliance in its research initiatives, ensuring that all trials contribute to the overall enhancement of public health and the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Miriam Driscoll, MD
Principal Investigator
UBC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials